U.S. Banks Stock News

Stryker (SYK) is back in focus after a cyberattack disrupted its manufacturing and electronic ordering systems, with the company now reporting restored access across most sites and renewed progress on production and fulfillment. See our latest analysis for Stryker. The recent cyberattack headlines come after a weaker patch for the stock, with a 30 day share price return of a 14.7% decline and a 1 year total shareholder return of a 9.3% loss, pointing to fading momentum despite positive multi...

Earlier this week, Progress Software announced that its ShareFile document collaboration platform now supports eIDAS-compliant Advanced and Qualified Electronic Signatures for UK and EU customers, integrating identity verification via Qualified Trust Service Providers into a single, auditable workflow. This move positions ShareFile as an all-in-one workspace for regulated industries, consolidating collaboration, high-assurance signing, and secure storage without relying on separate...

Earlier this week, Gates Industrial Corporation, a manufacturer of engineered power transmission and fluid power solutions, was lifted by easing geopolitical tensions as postponed military action against Iran reduced perceived risk for globally exposed industrial companies. This shift in geopolitical risk sentiment matters for Gates because its end markets, including construction equipment and manufacturing, are closely tied to global economic stability and confidence in longer-term capital...

If you are wondering whether Ligand Pharmaceuticals at around US$195 a share still offers value, the next sections will walk through what the current price might be implying about the business. The stock has delivered an 81.6% return over 1 year and 165.7% over 3 years, while the shorter term picture shows a 4.6% decline over 7 days alongside modest gains of 2.1% over 30 days and 2.8% year to date. Recent coverage of Ligand Pharmaceuticals has focused on its role in the wider pharmaceuticals...

Sportradar Group (NasdaqGS:SRAD) has introduced Playradar, a new iGaming brand that combines live sports streaming with casino style gaming experiences. The company has also expanded its relationship with Hard Rock Bet to include official PGA TOUR and UFC data plus more advanced in play betting features. These updates extend Sportradar's role beyond core sports data into hybrid gaming products while deepening ties with a major US betting operator. Sportradar Group, trading at $17.15, is...

For investors considering whether Broadridge Financial Solutions at around US$157 a share offers good value right now, this article walks through what the current price might be implying about the company. The stock has recently seen a 9.7% decline over the last 7 days, an 11.2% decline over 30 days, and is currently showing a 28.6% decline year to date and a 32.6% decline over 1 year. These moves may change how you think about its potential and its risks. Recent coverage has focused on...

On March 16, 2026, at its Global Conference, XP Inc. drew attention as analysts highlighted a stronger-than-expected start to the year driven by heavier retail equity trading and anticipated client reimbursements from Brazil’s deposit insurance fund (FGC) flowing back into XP’s platform. The interesting angle for investors is how these FGC-related inflows, if reinvested into fixed-income products, could generate upfront commissions that temporarily enhance XP’s revenue mix and fee...

Sports and golf expansion puts BrightView’s specialty work in focus BrightView Holdings (BV) is drawing fresh attention after expanding its Sports and Golf portfolios, adding new golf course maintenance contracts and featuring at globally recognized sporting events as the Official Field Consultant of Major League Baseball. See our latest analysis for BrightView Holdings. Despite the fresh sports and golf contracts, BrightView’s share price has had a weaker patch recently, with a 30 day share...

In recent commentary on Cullen/Frost Bankers, analysts highlighted that while Frost Bank’s prior quarterly results were solid, its revenue growth over the past two years has slowed relative to peers and its own five-year trend. An interesting takeaway is that consensus now points to a projected decline in tangible book value per share over the next 12 months, raising fresh questions about the bank’s capital generation and profitability outlook. Next, we’ll examine how slowing revenue growth...

Recent headlines around Kaplan, a core Graham Holdings (GHC) education subsidiary, have caught investor attention as Fast Company named it one of the World’s Most Innovative Companies of 2026 for its use of artificial intelligence. See our latest analysis for Graham Holdings. Despite the upbeat headlines around Kaplan’s AI recognition and new university partnerships, Graham Holdings’ share price has been comparatively muted. The company has seen a 5.34% 90 day share price return decline and a...

On 19 March 2026, X-energy Reactor Company and Talen Energy signed a Letter of Intent to assess deploying X-energy's Xe-100 small modular reactors in Pennsylvania and across the PJM market, including feasibility studies, site evaluations, and a potential transition of fossil-fired sites to nuclear. This early-stage collaboration highlights a possible path for Talen to expand clean baseload capacity while reusing existing transmission infrastructure and workforce at legacy fossil generation...

Cushman & Wakefield recently appointed Victoria Lake as CFO for APAC and EMEA and released its 2026 Americas Office Fit Out Cost Guide, which reports a 5.5% year-over-year rise in office fit-out costs across 59 markets. The guide’s findings, including contractors’ expectations of further labor and material cost increases amid a 25-year low office construction pipeline, highlight mounting cost pressures that could influence how landlords, tenants, and investors approach office space...

If you are wondering whether Medtronic is offering good value right now, you are not alone, especially with so much focus on entry price and long term returns. The stock last closed at US$87.14, after a 1.1% gain over the past week, a 9.8% decline over 30 days, a 9.3% decline year to date, and a 2.6% return over the past year. Recent headlines around Medtronic have centered on its position as a major medical technology company and ongoing interest from investors who follow large, established...

If you are wondering whether Boyd Gaming is priced fairly or if the market is missing something, this breakdown will help you assess what you are really paying for at the current share price. The stock last closed at US$80.16, with a 1.1% decline over the past week and a 5.6% decline over the past month. Over longer periods, the 1 year return is 22.1%, and the 3 year and 5 year returns are 28.8% and 36.1% respectively. Recent attention on Boyd Gaming has focused on its share price...

Aptiv (NYSE:APTV) announced that Javed Khan, Executive Vice President and President of Intelligent Systems, is resigning to become CEO of a software and AI company. CEO Kevin Clark will take on Khan's responsibilities on an interim basis while Aptiv searches for a successor. Aptiv shares recently closed at $67.04, with the stock showing a 10.6% gain over the past year, a 14.5% decline year to date, and a 40.2% decline over three years. The Intelligent Systems segment is an important area...

If you are wondering whether Corpay's current share price reflects its underlying worth, you are not alone. This article focuses squarely on what you might be paying for each dollar of quality in the business. Corpay recently closed at US$284.93, with returns of a 0.9% decline over 7 days, a 13.7% decline over 30 days, a 5.2% decline year to date, a 17.8% decline over 1 year, alongside longer term returns of 35.1% over 3 years and 1.9% over 5 years. Recent coverage has highlighted Corpay in...

Wondering if Portland General Electric at around US$51.71 is offering fair value right now, or if the recent share price leaves something on the table for you? The stock is up 1.5% over the past week and 6.7% year to date, while the last 12 months show a 22.0% return despite a 3.3% pullback over the past month. Recent attention on regulated utilities and the broader power grid story has kept Portland General Electric in focus, as investors weigh the role of electricity providers in long term...

If you are wondering whether Lazard at around US$39.11 is a bargain or a value trap, you are not alone. That question is exactly what this article aims to unpack. The stock has been under pressure recently, with a 0.4% decline over the last 7 days, a 24.3% decline over 30 days, and a 21.4% decline year to date. The 1 year return sits at a 5.6% decline, and the 3 year and 5 year returns are 36.7% and 11.2% respectively. Recent attention on Lazard has been driven by broader market...

Restaurant Brands International (NYSE:QSR) has appointed Chris Padoan as Chief Operating Officer for Popeyes U.S. and Canada. The company is expanding its Popeyes field operations team by 75% to support underperforming restaurants. These moves follow nearly 3% same store sales declines and weaker franchisee profitability at Popeyes. For investors tracking Restaurant Brands International at a share price of $71.42, this reset at Popeyes comes on top of a mixed recent return profile. The...

Why EZCORP (EZPW) Is On Investors’ Radar EZCORP (EZPW) has drawn attention after a period where the stock showed a mix of short term pullbacks and stronger longer term returns, prompting investors to reassess the pawn-focused lender’s recent performance and valuation. See our latest analysis for EZCORP. At a share price of US$25.21, EZCORP has seen a 27.1% 90 day share price return and a 71.8% 1 year total shareholder return, suggesting momentum has been building even with recent short term...

If you are wondering whether Western Union's share price reflects its true worth, it helps to step back and look at how the current market price lines up with the business fundamentals. The stock last closed at US$8.73, with returns of 3.2% decline over 7 days, 10.0% decline over 30 days, 5.4% decline year to date, 7.4% decline over 1 year, a 2.1% gain over 3 years, and a 49.1% decline over 5 years, which may suggest shifting views on its risk and reward profile. Recent coverage has focused...

Monte Rosa Therapeutics (GLUE) has moved into focus after signing a supply agreement with Johnson & Johnson to evaluate MRT-2359 plus ERLEADA in a planned Phase 2 trial for metastatic castration-resistant prostate cancer. See our latest analysis for Monte Rosa Therapeutics. Alongside the Johnson & Johnson supply agreement and fresh MRT-2359 data, Monte Rosa’s share price has eased recently. The stock has a 30 day share price return of 15% and a 90 day share price return decline of 11%. At the...

Brookdale Senior Living (NYSE:BKD) has been recognized as a "Best Pet Workplace" by WUF World. The company is the first senior living provider to receive this designation. The award highlights Brookdale's focus on pet friendly policies for residents and associates. Brookdale Senior Living, trading at $13.82, now carries a "Best Pet Workplace" label that sets it apart within the senior living space. Over the past year, the stock has returned 124.7%, and it is up 27.5% year to date. This may...

Gilead Sciences (NasdaqGS:GILD) agreed to acquire Arcellx in a US$7.8b deal. The transaction gives Gilead full rights to anito cel, a CAR T cell therapy for multiple myeloma. Anito cel has received fast track status and is being positioned as a next generation option in blood cancer treatment. For you as an investor, this move extends Gilead beyond its established antiviral and cell therapy work into a deeper role in hematologic oncology. Multiple myeloma is an area with significant...